(Q51640883)

8 April 2018

title

Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. (English)

1 reference

8 April 2018

1 reference

patent ductus arteriosus

1 reference

Pen-Hua Su

1

1 reference

8 April 2018

Jia-Yuh Chen

2

1 reference

8 April 2018

Chi-Ming Su

3

1 reference

8 April 2018

Tzu-Ching Huang

4

1 reference

8 April 2018

Hong-Shen Lee

5

1 reference

8 April 2018

publication date

1 December 2003

1 reference

8 April 2018

published in

Pediatrics International

1 reference

8 April 2018

volume

45

1 reference

8 April 2018

issue

6

1 reference

8 April 2018

page(s)

665-670

1 reference

8 April 2018

A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Treatment of patent ductus arteriosus with ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Cerebral vasoreactivity to arterial carbon dioxide tension in preterm infants: the effect of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Low-dose continuous indomethacin in early days of age reduce the incidence of symptomatic patent ductus arteriosus without adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Transcatheter closure of patent ductus arteriosus in an infant weighing 1180 g

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-200X.2003.01797.X

10.1111/J.1442-200X.2003.01797.X

21 January 2018

Identifiers

DOI

1 reference

8 April 2018

PubMed ID

14651538

1 reference

8 April 2018